Revised: 2/7/2020 - 1 -

CURRICULUM VITAE

Personal Information: Name: M. Patricia Rivera, MD, ACCP, ATSF Education: Fellow - Pulmonary Medicine (III)/Critical Care Medicine Memorial Sloan-Kettering Cancer Center/North Shore University Hospital July 1991 to June 1992 Fellow - Pulmonary Medicine (II) Memorial Sloan-Kettering Cancer Center, New York NY July 1990 to June 1991 Chief Resident - Internal Medicine Memorial Sloan-Kettering Cancer Center, New York NY July 1989 to June 1990 Fellow - Pulmonary Medicine (I) Memorial Sloan-Kettering Cancer Center, New York NY July 1988 to June 1989 Postdoctoral Training: Residency - Internal Medicine North Shore University Hospital, Manhasset NY July 1985 to June 1988 State University of New York at Stony Brook, School of Medicine M.D., June 1985 Pace University, New York, NY BS, June 1981 Summa cum laude Certification/Licensure: North Carolina - 1993 #93-00789 New York State - 1986 #169769 Board Certification: Pulmonary Diseases - 1994 Most recent re-certification: 2012 # 119518 American Board of Internal Medicine – 1988 # 119518 Employment History: Professor of Medicine with Tenure Pulmonary/Critical Care Division

Revised: 2/7/2020 - 2 -

University of North Carolina at Chapel Hill, Chapel Hill NC November 1, 2011 to present Director, Lung Cancer Screening Program University of North Carolina at Chapel Hill, Chapel Hill NC January 2015 to present Director of the UNC-Rex Pulmonary Practice University of North Carolina at Chapel Hill Rex Health Care system May 11, 2011 to April 30, 2014 Director, Pulmonary Function and Bronchoscopy Laboratory University of North Carolina at Chapel Hill, Chapel Hill NC January 2006 to Present Associate Professor of Medicine with Tenure Pulmonary/Critical Care Division University of North Carolina at Chapel Hill, Chapel Hill NC October 2004 to October 2011 Co-Director of the Multidisciplinary Thoracic Oncology Program 2009 to present Director of the Multidisciplinary Thoracic Oncology Program University of North Carolina at Chapel Hill, Chapel Hill NC March 2004 to March 2009 Director of Clinical Operations Division of Pulmonary and Critical Care Medicine University of North Carolina at Chapel Hill, Chapel Hill NC January 2006 to June 2011 Co-Director of the Pulmonary/Critical Care Fellowship Program University of North Carolina at Chapel Hill, Chapel Hill NC July 1996 to 2005 Assistant Professor of Medicine on Tenure Track Pulmonary/Critical Care Division University of North Carolina at Chapel Hill, Chapel Hill NC October 1998 to October 2004 Co-Founder and Co-Director of the Multidisciplinary Thoracic Oncology Program University of North Carolina at Chapel Hill, Chapel Hill NC January 1995 to March 2004 Clinical Assistant Professor of Medicine, Pulmonary/Critical Care Division University of North Carolina at Chapel Hill, Chapel Hill NC

Revised: 2/7/2020 - 3 -

January 1995 to September 1998 Physician, Department of Internal Medicine Kaiser Permanente, Raleigh, NC January 1994 to June 1994 Assistant Attending, Department of Medicine/Pulmonary Division Memorial Sloan-Kettering Cancer Center, New York NY July 1992 to July 1993 Clinical Assistant Professor, Department of Medicine Cornell University Medical College, New York NY July 1992 to July 1993 Fellow in Medicine Cornell University Medical College, New York NY July 1988 to June 1992 Honors and Awards: - 2019 Latin Medical Student Association Inaugural CHARLA Lecture - 2019 Distinguished CHEST Educator - 2019 ATS Assembly on Thoracic Oncology Lifetime Achievement Award

“Given to an individual who has made the most outstanding contributions in clinical, translational, or laboratory-based research relevant to the field of Thoracic Oncology”

- 2019-2020 Faculty Administrator Development Program (FADP) - 2019 Fellow of the American Thoracic Society - 2019 UNC Health Care and UNC Faculty Physicians Award for Carolina Care Excellence - 2019-2020 Guest Editor, Clinics in Chest Medicine: Lung Cancer Volume I and II, 2019-2020 - 2018 First Annual Pulmonary and Critical Care Division Faculty Teacher of the Year Award - 2017 CHEST Presidential Honor Lecture

“Honors an outstanding CHEST faculty member who is recognized for his or her exceptional experience in a given field”

- 2009-2019 Best Doctors in America - 2015 Nominated for ATS Elizabeth A. Rich Award - 2013 The First Annual Dorothy A. White, MD Memorial Lecture, Memorial Sloan Kettering Cancer Center - 2013 Co-recipient of an anonymous $100,000 gift to the UNC Lineberger Cancer Center to establish the Benjamin Calvo and M. Patricia Rivera Endowed Seed Grant Fund for Gastrointestinal and Thoracic Oncology Research - 2013 Guest Editor, Seminars in Respiratory and Critical Care Medicine Lung Cancer Volume 34 - 2011-2012 Liaison to the IASLC Society - 2006-2007 Nominated for the University of North Carolina at Chapel Hill Award for the Advancement of Women - 2003-2006 Best Doctors in America - 2004 Nominated by the Organization of Student Representatives Chapter of UNC Medical School for the Association of American Medical Colleges AMC Humanism in Medicine Award

Revised: 2/7/2020 - 4 -

- 2005 University of North Carolina School of Medicine White Coat Ceremony, Keynote Speaker - 2003-2004 Teaching Scholars Program University of North Carolina at Chapel Hill - 1998 University of North Carolina School of Medicine Richard H. Whitehead Lecturer

“Based on qualities of leadership, dedication, and devotion to medicine and teaching and in recognition of distinguished contribution to the science and art of medicine”

- 1990 American Society of Clinical Oncology - Travel Award - 1981 Summa cum laude Community Service Co-Founder and Member of the Board, the Fill Your Bucket List Foundation, 2014 - 2016 President, Board of Directors, Chapel Hill Cooperative Preschool 2000-2002 Vice-President, Board of Directors, Chapel Hill Cooperative Preschool 1998-2000 Treasurer, Board of Directors, Chapel Hill Cooperative Preschool-1997-1998 Bibliography: Books and Chapters

1. Rivera MP, Mody G, Weiner A. Treatment of Lung Cancer. In Murray & Nadel's Textbook of Respiratory Medicine. Section 1 Neoplasms of the Lung. 7e: V. Courtney Broaddus (Ed). In press

2. Rivera MP. Organization, quality and efficiency of lung cancer care delivery. In

Detterbeck FC, Tanoue L (Eds). Lung Cancer: A Practical Approach to Evidence-based Clinical Evaluation and Management of Care. Elsevier 2018. 159-167

3. Akulian J, Rivera MP. (2018) Tissue Acquisition in Patients with Suspected Lung

Cancer: Techniques Available to the Pulmonologist. In: Díaz-Jimenez J., Rodriguez A. (Eds) Interventions in Pulmonary Medicine (second Ed). Springer 2017. 299-312

4. Chang LH, Rivera MP. Clinical evaluation and staging of lung cancer: In Grippi MA,

Elias JA, Fishman JA, Kotloff RM, Pack AI, Senior RM (Eds). Fishman’s Pulmonary Diseases and Disorders. McGraw-Hill Education 2015; 1722-1732

5. Pathak V, Rivera MP. Tissue acquisition in patients with suspected lung cancer:

Techniques available to the pulmonologist. In Diaz-Jiménez JP, Rodriguez AN (Eds). Interventions in Pulmonary Medicine. Springer 2013;261-270

6. Weder MA, Rivera MP. Radiation-induced lung disease. In Camus P, Rosenow EC

(Eds). Drug-Induced and Iatrogenic Respiratory Disease. Edward Arnold Ltd. 2010; 161-71

7. Camus P, Rivera MP. Complicaciones torácicas de la radioterapia. En Mazzei JA,

Mazzei ME, Barro A, DiBartolo CG, (Eds.). Manual de Pruebas de Función Pulmonar-de lá fisiología a lá practica. Thompson Reuters-Prous Science., 2009; 285-90

Revised: 2/7/2020 - 5 -

8. Rivera MP. Pleural Effusion and Pneumothorax. In Runge MS, Greganti AM (Eds). Netter’s Internal Medicine. 2nd Edition. Saunders 2009;110-116

9. Rivera MP. Pleural Diseases. In Runge MS, Greganti AM (Eds). Netter’s Internal

Medicine. Icon Learning Systems. 2003;825-832

10. Rivera MP, Detterbeck FC, Loomis DP. Epidemiology and Classification of Lung Cancer. In Detterbeck FC, Rivera MP, Socinski MS, and Rosenman JG (Eds.). Diagnosis and Treatment of Lung Cancer: An Evidenced –Based Guide for the Practicing Clinician. W.B. Saunders Co., 2000; 25-44.

11. Martinolich K, Rivera MP. Pulmonary Assessment and Treatment. In Detterbeck FC,

Rivera MP, Socinski MS, and Rosenman JG (Eds.). Diagnosis and Treatment of Lung Cancer: An Evidenced- Based Guide for the Practicing Clinician. W.B. Saunders Co., 2000; 113-132.

12. Detterbeck FC, Rivera MP. Clinical Presentation and Diagnosis. In Detterbeck FC,

Rivera MP, Socinski MS, and Rosenman JG (Eds.). Diagnosis and Treatment of Lung Cancer: An Evidenced- Based Guide for the Practicing Clinician. W.B. Saunders Co., 2000; 45-72.

13. Bromberg P, Rivera MP. Hematological Disorders. In Sperber M, (Ed.). Diffuse Lung

Disorders. Springer, 1998; 263-294

14. Rivera MP, Stover DE. Lung Cancer. In Davis J (Ed.). Medical Management of Pulmonary Disease. Marcel Dekker Inc., 1998, 569 – 580.

15. Garofano S, Rivera MP, Stover DE. Bronchoscopy in the Immunocompromised Non-

Aids Patients. In Feinsilver HS, Fein AM, (Eds.). Textbook of Bronchoscopy. Williams & Wilkins, 1995; 242-263.

16. Stover DE, Rivera MP. Pulmonary Infections in the Immunocompromised Host. In

Pearson SG, Deslauries J, Ginsberg RJ, et al. (Eds). Thoracic Surgery. Churchill Livingstone Inc., 1995; 518-536.

17. Rivera MP, Jules-Elysse K, Stover DE. Respiratory Infections in Immunocompromised

Patients; Non-transplant, Chemotherapy Induced. In Niederman MS, Sarosi GA, Glassroth J, (Eds.). Respiratory Infections: A Scientific Basis for Management. W.B. Saunders, 1993; 163-180.

18. Stover DE, Rivera MP, Jules-Elysee K. Acquired Immunodeficiency Syndrome. In

Matthay, Matthay, Wiederman, (Eds.). Annual Review of Pulmonary and Critical Care Medicine 1991/92. Hanley and Belfus, 1992; 293-306.

19. Rivera MP, Pisters KW, Kris MG. Acute Toxicities of Cancer Chemotherapy. In

Groeger et al, (Eds.). Critical Care of the Cancer Patient. Yearbook Medical Publishers, 1990; 1-12.

Revised: 2/7/2020 - 6 -

Refereed papers/articles:

2019-2020 Submitted/Pending Review or Accepted/Pending Publication:

1. Rivera MP, Katki H, Triplette M, Tanner NT, Carter-Harris L, Crothers K, Carderelli R, Fathi JT, Ford M, Sakoda LC, Smith R, Wiener RS, Winn R, *Henderson L, *Aldrich M. Addressing Disparities in Lung Cancer Screening Eligibility and Health Care Access: An Official ATS Policy Statement. Submitted AJRCCM 2/2020

2. Gilbert CR, Wahidi MW, Light RW, Rivera MP, Sterman DH, Thomas R, Shojaee S, Shoham S, Pasllidas I, Ost DE, Molena D, Maskell N, Maldonado F, Livberman M, Lee G, Lee H, Herth FJF, Grosu H, Gorde JA, Fysh E, Corcoran JP, Argento AC, Akulian JA< Rahman NM, Yarmus LB. Management of Indwelling Tunneled Pleural Catheters: A Modified Delphi Consensus Statement. Submitted Chest 2/2020

3. Henderson LM, Bacchus L, Benefield T, Humani Velasquez R, Rivera MP. An Observational Study of Lung-RADS Reporting in Academic and Community Practices in North Carolina. Under review, Trans Lung Cancer Res, 12/15/2019

4. MacRosty C, Wright A, Ceppe A, Ghosh S, Belanger A, Burks AC, Rivera MP,

Akulian J. Pleural Fluid Resolution in Patients with Malignant Pleural Effusion is Associated with Improved Survival: An Analysis of Survival in Patients with Malignant Pleural Effusion in the Era of Next Generation Cancer Therapeutics. Under review, Chest 12/2019.

5. Sellers SA, Edmonds A, Ramirez C, Cribbs SK, Ofotokum I, Huang L, Morris A,

McCormack MC, Kunisaki KM, Rivera MP, Drummond MB, Adimora AA. Optimal lung cancer screening criteria among persons living with HIV. Submitted Lancet HIV 2/2020

6. Tabriz AA, Neslund-Dudas C, Turner K, Rivera MP, Reuland D, Elston Lafata J. How

Health Care Organizations Implement Shared Decision Making. When It Is Required for Reimbursement: The Case of Lung Cancer Screening. Under review Chest 12/2019

Published:

1. Haddad DN, Sandler KL, Henderson LM, Rivera MP, Aldrich MC. Disparities in Lung Cancer Screening: A Review. Ann Am Thorac Soc. 2020, February 4. doi:10.1513 [Epub ahead of print]

2. Rivera MP. Passion, Perseverance and Quantum Leaps: Lung Cancer in the 21st

Century. Clin Chest Med 2020;41:doi:10.1016

3. MacRosty C, Rivera MP. Lung Cancer in Women: A Modern Epidemic. Clin Chest Med. 2020;41:53-65

Revised: 2/7/2020 - 7 -

4. Silvestri GA, Bevill BT, Huang J, Brooks M, Choi Y, Kennedy G, Lofaro L, Chen A, Rivera MP, Tanner NT, Vachani A, Yarmus L, Pastis NJ. An evaluation of diagnostic yield from Bronchoscopy: the impact of clinical/radiographic factors, procedure type and degree of suspicion for cancer. Chest. 2020 Jan 21. [Epub ahead of print]

5. Bringhurst J, Weber DJ, Miller M, Rivera MP, Akulian J, Rutala WA,

Sickbert-Bennett EE. A Bronchoscopy-Associated Pseudo-Outbreak of Mycobacterium mucogenicum Traced to Use of Contaminated Ice Used for Bronchoalveolar Lavage. Infect Cont Hosp Ep. 2019 [Epub ahead of print]

6. Sears CR, Tobias P, Possick JD, Camus P, Gaga M, Garon ED, Gould MK, Naidoo J,

Nishino M, Patel SP, Limper AH, Montgrain P, Travis WD, *Rivera MP. Knowledge Gaps in Immune-checkpoint inhibitor-related pneumonitis: A Research Statement. Am J Resp Crit Care Med. 2019;200:e31-e43. *Co-Chair and Senior author

7. Burks CA, Gould MK, Silvestri GA, Yarmus LB, Nana-Sinkam P, Vachani A, Fuster

MM, Tanner NT, Wahidi MM, Arenberg DA, Gonzalez AV, Sears CR, Slatore CG, Tanoue LT, Rivera MP.* Safely and Effectively Evaluating CT Detected Lung Lesions: Much Work to be Done. Accepted Annals Am Thorac Soc 8/2019 * Senior author

8. Thiboutot J, Yarmus LB, Lee HJ, Rivera MP, Ost DE, Feller-Kopman D. Real-World

Application of the Navigate Trial. J Thorac Oncol. 2019 Jul;14(7):e146-e147

9. Long J, Petrov R, Haithcock B, Chambers D, Belanger A, Burks AC, Rivera MP, Ghosh S, MacRosty C, Delgado A, Akulian Perioperative Electromagnetic Transthoracic Nodule Localization for Minimally Invasive Pulmonary Resection. Ann Thorac Surg. 2019 Jun 21. pii: S0003-4975(19)30873-2. doi: 10.1016/j.athoracsur.2019.04.107. [Epub ahead of print]

10. Belanger A, Hollyfield J, Yacovone G, Ceppe AS, Akulian J, Burks C, Rivera MP,

Dodd L, Long JM, Haithcock BE, Pecot CV. Incidence and Clinical Relevance of NSCLC Lymph Node Micro-Metastasis Detected by Staging EBUS-TBNA. J Thorac Disease 2019;doi:10.21037/jtd.2019.05.36 [Epub ahead of print]

11. Henderson LM, Benefield TS, Bearden SC, Reuland, DS, Goldstein, AO, Throneburrg

A, Rivera, MP. Changes in physician knowledge, attitudes, beliefs, and practices regarding lung cancer screening. Annals Am Thorac Soc 2019; [Epub ahead of print]

12. Weiner RS, Rivera MP. Lung cancer screening programs in the United States:

Perpetuating the inverse care law. Chest 2019; 155:883-885

13. Rivera MP, Henderson L. Lung Cancer Screening and Shared Decision Making in Cancer Survivors: The Long and Winding Road. Trans Lung Cancer Res 2019;8(2):119-123

14. Rivera MP. Management of Malignant Pleural Effusions: Round and round we go.

Annals Am Thorac Soc 2019;16:59-61

Revised: 2/7/2020 - 8 -

15. Belanger A, Burks CA, Chambers DM, Ghosh S MacRosty C, Conterato A, Rivera

MP, Akulian JA. Peripheral Lung Nodule Diagnosis and Fiducial Marker Placement Using a Novel Tip-Tracked Electromagnetic Navigation Bronchoscopy System. J Bronchol Intervent Pulmonol 2019;26:41-48 [Epub ahead of print 2018]

16. Henderson LM, Marsh KM, Benefield T, Jones LM, Reuland D, Brenner A, Goldstein

A, Molina PL, Maygarden S, Rivera MP. Opinions and Practices of Lung Cancer Screening by Physician Specialty in a Large Academic Medical Center. NC Med J 2019;80:19-26

17. Cubillos L, Brenner AT, Birchard K, Henderson L, Jones L, Molina P, Pignone MP,

Ratner S, Rivera MP, Reuland DS. Multidisciplinary Quality Improvement Initiative to Standardize Reporting of Lung Cancer Screening. Transl Lung Cancer Res 2018;7 (Suppl 3): S297-S301

18. Rivera MP, Tanner NT, Silvestri GA, et al. Incorporating Coexisting Chronic Illness

into Decisions about Patient Selection for Lung Cancer Screening: An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med 2018; 198:e3-e13

19. Beattie J, Yarmus L, Wahidi M, Rivera MP, Gilbert C, Maldonado F, Czarnecka K.

Argento A, Chen A, Herth F, Sterman DH. The Immune Landscape of Non-Small Cell Lung Cancer: Utility of Cytologic and Histologic Samples Obtained Through Minimally Invasive Pulmonary Procedures. Am J Respir Crit Care Med. 2018;198: 24-38 [Epub ahead of print]

20. Henderson LM, Jones L, Marsh KM, Brenner AT, Goldstein AO, Benefield T,

Greenwood-Hickman MA, Molina P, Rivera MP, Rueland D. Opinions, Practice Patterns, and Perceived Barriers to Lung Cancer Screening among Attending and Resident Primary Care Physicians. Risk Manag and Healthc Policy 2018;10: 189–195

21. Brenner A, Cubillos L, Birchard K, Henderson L, Molina P, Pignone MP, Ratner S,

Rivera MP, Reuland DS. Improving the implementation of lung cancer screening guidelines at an academic medical center. J Healthc Qual. 2018;40:27-35 [Epub ahead of print 2017]

22. Henderson LM, Jones LM, Marsh MW, Benefield T, Rivera MP, Molina PL. Lung

Cancer Screening Practices in North Carolina CT Facilities. J Am Coll Radiol 2017; 14:166-170

23. Weiner RS, Gould MK, Arenberg D, Au DH, Fenning K, Lamb CR. Mazzone P,

Mithum DE, Napoli M, Ost DE. Powell CA, Rivera MP, Slatore CG, Tanner NT, Vachani A, Wisnivesky JP, Yoon SH. Official American Thoracic Society/American College of Chest Physicians Policy Statement: Implementation of lung cancer screening programs with low-dose computed tomography. Am J Respir Crit Care Med 2015; 192:881-891

Revised: 2/7/2020 - 9 -

24. Rivera MP. Lung Cancer in Women: Differences in epidemiology, biology, histology and treatment outcomes. Seminars in Respiratory and Critical Care Medicine. Guest Editor: M. Patricia Rivera, MD. Semin Respir Crit Care Med 2013;34:792-801

25. Rivera MP, Mehta A, Wahidi M. Establishing the diagnosis of lung cancer: Diagnosis

and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143(5 Suppl):e142S-65S.

26. Chang LH, Rivera MP. Respiratory Diseases: Meeting the Challenges of Screening,

Prevention, and Treatment. N C Med J. 2013;74(5):385-392.

27. Yirmibesoghu E, Higginson DS, Fayda M, Rivera MP, Halle J, Rosenman J, Xie L, Marks LB. Challenges scoring radiation pneumonitis in patients treated for lung cancer. Lung Cancer 2012; 76(3):350-3.

28. Wilcox E, Rivera MP, Sassoon C. Ware LB, Wunsch H, Herridge MS. "Clinical Year

in Review II", Proceedings of the American Thoracic Society, Vol. 9, No. 4 (2012), pp. 190-196

29. Rivera MP. Preinvasive Lesions of the Bronchus. Clin Chest Med. 2011; 32(4):693-

702.

30. Rivera MP. Lung Cancer in Women: a review of the differences in epidemiology, biology, and treatment outcomes. Expert Rev. Resp. Med. 2009; 3(6):627-34

31. Hall WB, Truitt SG, Scheunemann LP, Rivera MP, Parker LA, Carson SS. The

prevalence of clinically relevant incidental findings on chest computed tomography angiogram ordered to diagnose pulmonary embolism. Arch Intern Med 2009; 169:1961-65.

32. Lee CB, Stinchcombe TE, Moore DT, Morris DE, Hayes DN, Halle J, Rosenman JG,

Rivera MP, Socinski MA. Late complications of high-dose (>/=66 Gy) thoracic conformal radiation therapy in combined modality trials in unresectable stage III non-small cell lung cancer. J Thorac Oncol. 2009 Jan;4(1):74-9.

33. Rivera MP, Detterbeck FC, Socinski, MA, Moore DT, et al. Impact of Preoperative

Chemotherapy on Pulmonary Function Tests in Resectable Early-Stage Non-small Cell Lung Cancer. Chest 2009; 135:1588-1595.

34. Stinchcombe TE, Lee CP, Moore DT, Rivera MP, Halle J, Limentani S, Rosenman JG,

Socinski MA. Long-term follow-up of a phase I/II trial of dose escalating three-dimensional conformal thoracic radiation therapy with induction and concurrent carboplatin and paclitaxel in unresectable stage IIIA/B non-small cell lung cancer. J Thorac Oncol. 2008; 11:1275-89

35. Stinchcombe TE, Morris DE, Lee CB, Moore DT, Hayes DN, Halle JS, Rivera MP, et

al. Induction Chemotherapy with Carboplatin, Irinotecan, and Paclitaxel Followed by High Dose Three-Dimension Conformal Thoracic Radiotherapy (74 Gy) with

Revised: 2/7/2020 - 10 -

Concurrent Carboplatin, Paclitaxel, and Gefitinib in Unresectable Stage IIIA and Stage IIIB Non-Small Cell Lung Cancer. J Thorac Oncol. 2008; 3:250-7.

36. Stinchcombe TE, Detterbeck FC, Lin L, Rivera MP, Socinski MA. Beliefs among

physicians in the diagnostic and therapeutic approach to non-small cell lung cancer. J Thora Oncol 2007; 2:819-26.

37. Rivera MP, Mehta A. Initial Diagnosis of Lung Cancer: ACCP Evidence-Based

Clinical Practice Guidelines (2nd Ed). Chest 2007; 132(S Suppl):131S-148S.

38. Flake GP, Rivera MP, Funkhouser WK, Maygarden SJ, Meadows KL, et al: Detection of Pre-Invasive Lung Cancer: Technical Aspects of the LIFE Project. Toxicol Pathol 2007; 35:65-74.

39. Yim HW, Slebos RJC, Randell SH, Umbach DM, Parsons AM, Rivera MP,

Detterbeck FC, Taylor JA: Smoking is Associated with Increased Telomerase Activity in Short-Term Cultures of Human Bronchial Epithelial Cells. Cancer Lett 2007; 246:24-33.

40. Biehn SE, Kirk D, Rivera MP, Martinez AE, Khandani AH, Orlowski RZ.

Bronchiolitis Obliterans with Organizing Pneumonia after Rituximab Therapy for Non-Hodgkin’s Lymphoma. Hematology Oncology 2006; 24:234-7.

41. Chalermskulrat W, Sood N, Neuringer IP, Hecker TM, Chang L, Rivera MP,

Paradowski LJ, Aris RM. Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation. Thorax. 2006 Jun;61(6):507-13.

42. Silvestri GA, Rivera MP. Targeted Therapy for the Treatment of Non-Small Cell Lung

Cancer: A Review of the Epidermal Growth Factor Receptor Antagonists. Chest 2005; 128:3975-3981.

43. Slebos RJ, Livanos E, Yim HW, Randell SH, Parson AM, Detterback FC, Rivera MP,

Taylor JA. Chromosomol Abnormalities in Bronchial Epithelium from Smokers, Nonsmokers and Lung Cancer Patients. Cancer Genet Cytogenet 2005; 159(2):137-42.

44. Rivera MP. Lung Cancer in US Minorities. Pulmonary Perspectives 2005; 22(4): 5-7.

45. Socinski MA, Morris DE, Halle JS, Moore DT, Hensing TA, Limentani SA, Fraser R,

Tynan M, Mears A, Rivera MP, et al. Induction and Concurrent Chemotherapy with High-Dose Thoracic Conformal Radiation Therapy in Unresectable Stage IIIA and IIIB Non-Small Cell Lung Cancer: A Dose-Escalation Phase I Trial. J Clin Oncol 2004; 22(21):4341-50.

46. Detterbeck FC, Falen S, Rivera MP, Halle JS, Socinski MA. Seeking a Home for a

PET, Part II: Defining the Appropriate Place for Positron Emission Tomography Imaging in the Diagnosis of Pulmonary Nodules or Masses. Chest 2004; 125(6):2300–8.

Revised: 2/7/2020 - 11 -

47. Detterbeck FC, Falen S, Rivera MP, Halle JS, Socinski MA. Seeking a Home for a PET, Part I: Defining the Appropriate Place for Positron Emission Tomography Imaging in the Diagnosis of Pulmonary Nodules or Masses. Chest 2004; 125 (6)2294 – 9.

48. Rivera MP. Multimodality Therapy in the Treatment of Lung Cancer. Targeted

Therapy in the Multimodality Treatment of Lung Cancer (MP Rivera Guest Editor) Seminars in Pulmonary and Critical Care Medicine. 2004; 25 (1): 3-10.

49. Rivera MP, Stover DE. Gender and Lung Cancer. Clin Chest Med. 2004; 25(2):391-

400.

50. Rivera MP, Detterbeck FC, Mehta AC. Diagnosis of Lung Cancer: The Guidelines. Chest 2003; 123(1): 129S- 136S.

51. Jett, JR, Scott WS, Rivera MP, Sausse WT. Guidelines on Treatment of Stage IIIB

Non-Small Cell Lung Cancer. Chest 2003;123(1): 221S-225S.

52. Socinski MA, Rivera MP, Detterbeck FC. Gemcitabine-Based Combinations as Preoperative Therapy in Resectable Non-Small Cell Lung Cancer. Clinical Lung Cancer 2003; 2:S50-5.

53. Kudrik FJ, Rivera MP, Molina PL, Maygarden S, Socinski MA. Hypersensitivity

Pneumonitis in Advanced Non-Small Lung Cancer Patients Receiving Gemcitabine and Paclitaxel: Report of two cases and a review of the literature. Clinical Lung Cancer 2002; 4: 52-56.

54. Rivera MP. Management of patients with advanced non-small cell lung cancer.

Current Opinions in Pulmonary Medicine. 2001; 7: 247-251.

55. Socinski MA, Rosenman JG, Schell MJ, Halle J, Rivera MP, et al: Induction carboplatin/paclitaxel followed by concurrent carboplatin/paclitaxel and dose-escalating conformal thoracic radiation therapy in unresectable stage IIIA/B non-small cell lung carcinoma: a modified Phase I trial. Cancer 2000; 89: 534-42.

56. Schroen AT, Detterbeck FC, Crawford R, Rivera MP, Socinski MA: Beliefs Among

Pulmonologists and Thoracic Surgeons in the Therapeutic Approach to Non-small Cell Lung Cancer. Chest 2000;118:129-137.

57. Reif MS, Socinski MA. Rivera MP. Evidence-Based Medicine in the Treatment of

Non-Small Cell Lung Cancer. Clin Chest Med. 2000; 21: 107-20.

58. Reif MS, Rivera MP. Evidence-Based Outcomes for Patients with Advances Non-Small Cell Lung Cancer. Semin Respir Crit Care Med. 2000; 21:443-9.

59. Rivera MP. Evidence- Based Medicine in the Treatment on Advanced Non-Small Cell

Lung Cancer. Semin Respir and Crit Care Med 2000; 21: 443-449

Revised: 2/7/2020 - 12 -

60. Socinski MA, Detterbeck FC, Rivera MP, et al. Chemotherapy Helps Patients with Advanced Non-Small Carcinoma of the Lung. NC Med J. 1996; 57:281-6.

61. Rivera MP, Kris MG, Gralla RJ, White DA: Syndrome of Acute Respiratory Distress

Related to Combined Mitomycin-Vinca Alkaloid Therapy. Am J Clin Oncology 1995;18: 245-250.

62. Stover DE, Rivera MP: Difficult Differentials: Is it Lung Cancer or Not. Primary Care

and Cancer 1993;13:36-43. Digital Presentations/Published interviews:

1. Ghosh S, Chambers D, Belanger A, Burks AC, MacRosty C, Conterato A, Long J, Haithcock B, Rivera MP, Akulian JA. Electromagnetic Navigation Transthoracic Nodule Localization for Minimally Invasive Thoracic Surgery. Journal of Visualized Experiments 2019. In Press.

2. Rivera MP, Silvestri GA. February CHEST Physician. Lung cancer screening complication risk: Further reflections. CHEST Physician 2019. https://www.mdedge.com/chestphysician/article/195983/mixed-topics/february-chest-physician-story-lung-screening

3. Rivera MP, MD. Updates in lung cancer 2018: What the pulmonologist needs to know

Oncology & Hematology Review. 2019;15(1): Epub ahead of print 4. CHEST Clinical Perspectives Webinar: Delays in Diagnosis: Barriers to Efficient and

Accurate Pulmonary Evaluation. Rivera MP. 12/2018 5. Lung Cancer Screening. Rivera MP. OncLive 4/2018 6. CME / ABIM MOC. Clinical Pearls on the Management of Immune-Mediated Adverse

Events Affecting the Lung. Authors: Jarred Weiss, MD, M Patricia Rivera. 4/2018 7. CME / ABIM MOC. Moving the Goal Post: Multidisciplinary Management of Advanced

NSCLC. Authors: Suresh S. Ramalingam, MD; M. Patricia Rivera, MD; Ignacio I. Wistuba, MD. 12/19/2017

8. CME / ABIM MOC. Pulmonologist Perspectives: How Will the Use of Immune

Checkpoint Inhibitors Affect My Practice. Authors: Gerard Silvestri MD, M. Patricia Rivera, MD. 5/2016

9. ATS Breathe Easy Podcasts: Lung Cancer Screening Implementation: A Serial Discussion. Christopher Slatore, MD. M. Patricia Rivera, Renda Weiner, MD. October 2016

10. CME / ABIM MOC. Fundamental Concepts in the Diagnosis of Advanced NSCLC.

Author: Gerard Silvestri, MD, James Finegan, MD, M. Patricia Rivera, MD. 10/2016

Revised: 2/7/2020 - 13 -

11. CME / ABIM MOC. Where Bench and Bedside Meet: Molecular Assessment and Clinical Application in Advanced NSCLC. Authors: Georgio Scagliotti MD, M. Patricia Rivera, MD, Ming-Sound Tsao 2/2014

12. CME/ABIM MOC. Optimum Staging, Genetic Analysis, and Treatment of NSCLC: The

Role of the Pulmonologist” Authors: Gerard Silvestri, MD, M Patricia Rivera, MD 10/2012

Published Abstracts

1. Henderson LM, Sites S, Throneburg A, Charlot M, Samulski TD, Marsh MW, Lane LM, Rivera MP. Evaluating Predictors of Biomarker and PD-L1 Testing in Advanced Stage Lung Cancer Patients. ATS Annual Meeting May 2020, Accepted for Poster Presentation at the American Thoracic Society Annual Meeting. May 15-20, 2020. Philadelphia, PA.

2. Atchley WT, Alvarez C, Beem SS, Schwartz TA, Ishizawar RC, Patel KP, Rivera MP. Immune Checkpoint Inhibitor-related Pneumonitis in Lung Cancer: A Retrospective Multi-Site Assessment of Real-world Incidence, Risk-factors, And Management Practices. Accepted for Poster Presentation at the American Thoracic Society Annual Meeting May 15-20, 2020, Philadelphia, PA * Selected for ATS TOA Award

3. Rivera MP, Van Dyk M, Tailor TD, Jason Long J , Sites S, Bearden C, Alston-Johnson D, Ciociola EC, Henderson LM. Lung Cancer Screening in Patients with versus Without a Personal History of Cancer. NAISLC 2019

4. Elston-Lafata J, Tabrizi A, Rivera MP, Reuland DS, Neslung-Duda C. Adoption and Implementation of Shared Decision Making for Lung Cancer Screening. ICCH October 2019 Abstract Number: 267

5. Henderson LM, Sites S, Tailor TD, Bearden SC, Huamani R, Throneburg A, Rivera MP.

Lung Cancer Screening in Academic and Community Practice: A Tale of Two Cities. ATS annual meeting May 2019, Dallas: Abstract Number 13570

6. Henderson LM, Sites S, Tailor TD, Bearden SC, Huamani R, Throneburg A, Rivera MP

Factors Associated with Adherence to Lung Cancer Screening in Academic and Community Settings. International Cancer Screening Conference, June 2019 Abstract Number: 207

7. Henderson LM, Sites S, Tailor T, Bearden SC, Huamani R, Throneburg A, Nagle M,

Rivera MP. Patient and Screening Characteristics Associated with Positive Lung Cancer Screening Examinations. AACR annual meeting, April 2, 2019: A4215

8. Sellers SA, Edmonds A, Ramirez C, Cribbs S, Ofotokun I, Huang L, Morris A,

McCormack MC, Kunisaki KM, Rivera MP, Drummond MB, and Adimora A. Optimal Lung Cancer Screening Criteria Among Persons Living with HIV. Oral presentation. Conference on Retrovirals and Opportunistic Infections; 2019 March (Seattle, WA); Abstract #15.

Revised: 2/7/2020 - 14 -

9. Henderson L, Marsh MW, Pritchard MA, Benefield TS, Molina PA, Rivera MP. Lung

Cancer Risk and characteristics of Adults Undergoing LDCT Lung Cancer Screening. Am J Respir Crit Care Med 2018;197:A5975

10. MacRosty, C., Wright, A., Chambers, DM, Ghosh, S., Belanger AR, Burks, C., Rivera,

MP. Akulian, J. Prognostic Factors in Patients Diagnosed with Malignant Pleural Effusion. Am J Respir Crit Care Med 2018; 197:A6423 *Selected for ATS TOA Award

11. Austin CA, Birchard K, Rea D, Dover K, Akulian JA, Rivera MP. Analysis of Chest

Lymphadenopathy and Granulomatous Changes in Post-Treatment Non-Lung Non-Lymphoma Malignancy Patients. Am J Respir Crit Care Med 2017;1471: A4563

12. Desai H, Akulian JA, Belanger A, Rivera MP, Bacchus L, Murdock B, Molina P,

Birchard K. Cost-Effectiveness of Electromagnetic Navigational Bronchoscopy and CT-Guided Transthoracic Needle Biopsy for Diagnosis of Pulmonary Nodules with Consideration for Diagnostic Efficacy and Complications. Am J Resp Crit Care Med 2017; 919: A2881

13. Henderson LM, Jones LM, Benefield T, Reuland D, Brenner A, Molina P, Rivera MP.

Appropriateness of Lung Cancer Screening with Low Dose Computed Tomography. IASLC; 2016; 201:5647

14. Henderson LM, Molina P, Birchard K, Bowling JM, Maygarden S, Reuland D, Marsh

MW, Greenwood-Hickman MA, Jones L, Rivera MP. Development of a Lung Cancer Screening Registry. Am J Respir Crit Care Med 2016; 193: A1283

15. Reuland D, Brenner A, Cubillos L, Henderson L, Rivera MP, Birchard KB, Harris R,

Pignone M. Using Deliberate Methods to Guide Implementation of Lung Cancer Screening. Society for Medical Decision Making 2015

16. Truitt SG, Hall WB, Rivera MP, et al: Incidental Pulmonary Nodules found on CT

Angiograms: Characteristics and Recommended Follow Up. ATS 2008; 177:A404

17. Kennedy MP, Hayes DH, Rivera MP: Bronchioloalveolar Carcinoma Presenting as a Flu-like Illness with Bilateral Cavitary Pneumonia and Pseudo Abscess. Chest 2005; 128:473S-474S

18. Rivera MP, Detterbeck FC, Socinski MA, et al: Neoadjuvant Chemotherapy with

Gemcitabine-Containing Regimens in Stage I-II Non-Small Cell Lung Cancer (NSCLC): Initial Results of Pre-Operative Pulmonary Function Testing (PFT) in the GINEST Project. ASCO 2005; S7227:P677

19. Maygarden SJ, Funkhouser WK, Flake G, Slebos R, Taylor J, Rivera MP: Comparison

of biopsy and cytology samples taken with the Light Induced Endoscope (LIFE) bronchoscopy system. USCAP 2004; 65-74

Revised: 2/7/2020 - 15 -

20. Rivera MP, Slebos RJ, Funkhouser WK, et al: Detection and Follow-Up of Premalignant Bronchial Lesions Using Laser-Induced Fluorescence Endoscopy (LIFE) in Patients at High Risk for Lung Cancer. IASLC 2003; S160: P-271.

21. Yim HW, Slebos RJ, Randell SH, Parsons AM, Rivera MP, et al: Telomerase

Activation and p16 Methylation Status in Short-Term Cultures on Human Bronchial Epithelia (HBE) Cells. IASLC 2003; S119: P-115.

22. Slebos RJ, Livanos E, Yim HW, Randell SH, Parson AM, Detterbeck FC, Rivera MP, et

al: Chromosomal Abnormalities in Bronchial Epithelium from Smokers, Non-Smokers and Lung Cancer Patients. IASLC 2003; S165: P- 288.

23. Slebos RJ, Rivera MP, Umbach DM, et al: Loss of Heterozygosity in Bronchial

Epithelium Obtained with Fluorescent Bronchoscopy from Patients at High Risk for Lung Cancer. IASLC 2003; S165: P-289.

24. Chalermskulrat W, Rivera MP: Rapidly Developing Nodules After Lung Transplantation

Chest 1999; 61(6): 507–513.

25. Kaner R, Garofano S, Rivera MP, et al: Bronchoalveolar Lavage Findings After Mitomycin Combination Chemotherapy for Non-Small Cell Lung Cancer. Am J Respir and Crit Care Med 1995; 151:A201.

26. Rivera MP, Kris MG, Gralla R, White DA: Incidence and Syndrome of Acute Shortness

of Breath Following Vinca Alkaloid Therapy in Patients with Lung Cancer Receiving Mitomycin. Proceedings ASCO 1990; 9:322.

27. Rivera MP, Kris MG, Gralla R, White DA: Acute Episodes of Deterioration During

Therapy with Mitomycin and Vinca Alkaloid Therapy. Chest 1989; 96: 217S. Refereed Unpublished Invited Oral Presentations, National and International: 2020 The 64th Annual Tri-State Conference, January 17, 2020 New Orleans, Louisiana Keynote Speaker: “Immunotherapy in Lung Cancer: The Good, The Bad and The Ugly” 2019 Third Annual American Cancer Society Lung Cancer RoundTable Forum, December 8-10, 2018 Washington DC Speaker “Optimizing Lung Cancer Biomarkers in Practice” The 15th International Symposium on Respiratory Diseases & ATS Forum, Shanghai, China, October 23-27, 2019 Speaker: “Lung Cancer in Women: Biologic Differences”

Revised: 2/7/2020 - 16 -

American College of Chest Physicians Annual Meeting October 17-23, 2019 New Orleans, Louisiana

Solitary Pulmonary Lung Nodule Fellows Program Speaker: “Disparities in Lung Cancer Care” Co-Chair “Post Graduate Course: Lung Cancer 2019: Important Advances and Practice Implications”

Speaker: “Lung Cancer Screening – NLST and the NELSON Trial: Where Do We Go from Here?” Speaker: “Oligometastatic Disease: What Is It and What Does It Mean? Oligometastatic Disease”

Speaker: “Not All Are Created Equal: Disparities in Lung Cancer Screening” Speaker: “Lung Cancer in Women: A Modern Epidemic” Speaker: “8th International TNM Staging for Lung Cancer: “Classification of Multiple Lung Nodules”

North America Annual IASLC Conference on Lung Cancer October 10-12, Chicago, Illinois Opening and Keynote Lecture “Disparities in Lung Cancer Screening” American Thoracic Society Annual Meeting May 17-22, 2019

Co-Chair Post Graduate Course: Lung Cancer 2019 Speaker: “The Expanding Role of Immunotherapy in the Treatment of Lung Cancer”

Co-Chair: Addressing Disparities in Lung Cancer Screening Eligibility and Health Care Access Co-Chair: What Pulmonologists Need to Know About Cancer Immunotherapy American Thoracic Society Fellows Track Symposium

Speaker: “Lung Cancer: Year in Review” Co-Chair: Addressing Disparities in Lung Cancer Screening Eligibility and Health Care Access, May 18th, 2019

UNC-John Hopkins Conference: Updates in Lung Cancer, Immunotherapy and Immune-related Toxicity: The Fourth Year, May 6, 2019 Speaker “Lung Cancer Screening in 2019” The University of Illinois Cancer Center’s 2019 Dr. Gary Kruh Cancer Research Symposium, Chicago Ill April 17, 2019 Speaker “Disparities in Clinical Trial Enrollment in Lung Cancer” American Cancer Society National Lung Cancer RoundTable: Lung Cancer in Women Task Force Summit February 11, 2019 Speaker: “The Biology of Lung Cancer in Women” 2018 Second Annual American Cancer Society Lung Cancer RoundTable Forum, Washington DC December 11-12, 2018 Speaker “Top Five Most Influential Papers in Lung Cancer in 2018”

Revised: 2/7/2020 - 17 -

14th International Symposium on Respiratory Diseases & ATS Forum, Xiamen China, November 17-21, 2018 Speaker: “Lung Cancer in Women: Differences in Risk and Benefits in Screening” “Immunotherapy in Lung Cancer: Comprehensive Update” American College of Chest Physicians October 4-10, 2018 San Antonio Texas

Co-Chair “Lung Cancer Post Graduate Course” Speaker: “Implementation of Lung Cancer Screening: Opportunities and

Challenges” Speaker: “Molecular Biomarker Testing in Lung Cancer: What the Chest Physician Needs to Know” Speaker: 8th International TNM Staging for Lung Cancer: “Classification of Multiple Lung Nodules” Speaker: “Immunotherapy in Lung Cancer: The Good and the Bad” Speaker: “Breakthroughs in the Treatment of Advanced Lung Cancer: What the Pulmonologist Needs to Know”

International Association of the Study of Lung Cancer September 23-26, 2018 Speaker: “Symptom Management in Patients with Lung Cancer” XXXXII Congresso Brasileiro De Pneumologia E Tisiologia, Goiânia, Brazil, August 4-7, 2018 “Métodos diagnósticos en Cáncer de Pulmón”

“Cáncer De Pulmón En La Mujer” American Thoracic Society Annual Meeting May 18-25, 2018

Co-Chair Post Graduate course: Lung Cancer 2017 Speaker: “The Top Five Articles in Lung Cancer 2017-2018”

Co-Chair Optimizing Selection of Screen Eligible Patients Co-Chair: Knowledge Gaps in Immunotherapy Induce Lung Injury: A Research Agenda Workshop Friday May 18, 2018

Conferencia XIII Enfoque Multidisciplinario de Cáncer de Pulmón Buenos Aires Argentina May 9-11 2018 “Lung Cancer Screening: Barriers to Implementation” “Cáncer De Pulmón En La Mujer”

“Complicaciones Respiratorias De Los Nuevos Tratamientos Sistémicos En Cáncer Del Pulmón” “Participante Mesa Redonda: El Tratamiento Multidisciplinario Del Cáncer De Pulmón”

Visiting Professor, Facultad de Medicina de Oviedo, Oviedo Spain, February 5 2018 “Tratamiento del Cáncer de Pulmón: Un Desafío Para la Ciencia Barcelona-Boston Lung Conference, Facultad de Medicina de Barcelona, Barcelona Spain, February 2-4 2018 “Treatment of Non-Operable Lung Cancer”

Revised: 2/7/2020 - 18 -

2017 13th International Symposium on Respiratory Diseases & ATS Forum, Shanghai China, November 16-18, 2017 Speaker: “Lung Cancer in Women: A Worldwide Epidemic” “Treatment of Advanced NSCLC: Targeted and Immunotherapy” “Lung Cancer Screening: Where are We?” VI Jornada Bienal Internacional EPOC Zaragoza, Spain November 2-4 2017 “Cáncer en EPOC” Participante, Mesa Redonda. American College of Chest Physicians October 27-31, 2017 Presidential Honor Lecture “Passion, Perseverance and Quantum Leaps: Advances in Lung Cancer Care”

Co-Chair “Lung Cancer Post Graduate Course” Speaker: “Implementation of Lung Cancer Screening: Opportunities and Challenges” Speaker: 8th International TNM Staging for Lung Cancer: “Classification of Multiple Lung Nodules” Co-Chair “Immunotherapy in NSCLC: What the pulmonologist needs to know” Participant, “Combined ACCP/AATS Thoracic Oncology Tumor Board”

ASCO Advantage: “Non-small Cell Lung Cancer” Georgetown University August 2017 Speaker: “Screening for Lung Cancer: Update” American Thoracic Society Fellows Track Symposium May 19, 2017 Speaker: “Lung Cancer: State of the Art” American Thoracic Society Annual Meeting May 19-25, 2017 Co-Chair Post Graduate course: Lung Cancer 2017 Speaker: “Lung Cancer Screening: Where Are We Now?” Meet the Professor Seminar: “Lung Cancer in Women”

Lung Cancer Screening and Tobacco Treatment Symposium Speaker: “Lung Cancer Screening and Tobacco Treatment in Minorities”

Chair: Evaluation of Coexisting Chronic Illness in Selecting Patients for Lung Cancer Screening: A Research Agenda Workshop Saturday May 20,2017

American Association for Cancer Research April 2, 2017 Lung Cancer Disparities and Behavioral Strategies for Equity

Speaker: “Landscape of disparities in lung cancer care” 2016 American College of Chest Physicians October 21-27, 2016 Co-Chair “Lung Cancer Post Graduate Course” Participant “Combined ACCP/AATS Thoracic Oncology Tumor Board” 44th Congreso Argentino de Medicina Respiratoria October 7-10 2016 Speaker:

“Screening for Lung Cancer”

Revised: 2/7/2020 - 19 -

“Pulmonary Nodule Assessment” “Lung Cancer in Women” “The Role of the Pulmonologist in Multidisciplinary Lung Cancer Care” Eastern Pulmonary Conference September 8-11, 2016

Speaker: “Paradigm Shifts in Treatment of Non-Small Cell Lung Cancer: Novel Therapies”

Speaker: “Screening for Lung Cancer: Patient Selection” American Thoracic Society Annual Meeting May 16-22, 2016 Co-Chair Post Graduate course: Lung Cancer 2016 Speaker: “Disparities in Lung Cancer Care” Speaker: “Lung Cancer in Minorities” 2015 American College of Chest Physicians October 25-28, 2015 “Differences in the Epidemiology of Lung Cancer” Cleveland Clinic 9th Annual Navigational Bronchoscopy Summit June 5, 2015 Keynote Address: “Lung Cancer Screening: Balancing the Benefits and the Harms” American Thoracic Society Annual Meeting May 15-20, 2015 Co-Chair: Post Graduate Course: Lung Cancer 2015 Speaker: “Small Cell Lung Cancer” Co-Chair Lung Diseases in Women Speaker “The Specter of Gender: Lung Cancer in Women” American Thoracic Society Fellows Track Symposium May 15, 2015 Speaker: “New Paradigms in Lung Cancer Screening, Diagnosis and Treatment” 2014 American College of Chest Physicians Annual Meeting October 27-31, 2014 Disparities in Lung Cancer: Linking Clinical to Scientific Understanding

Speaker: “Understanding the Epidemiology and Biology of Lung Cancer Across Gender”

American Thoracic Society Annual Meeting May 15-20, 2014 Co-Chair: Post Graduate Course: Lung Cancer 2014

Speaker: “Complications of Treatment for Lung Cancer”

Cleveland Clinic Advanced Diagnostic Bronchoscopy Workshop April 25-26, 2014 Keynote Lecture: “New Paradigms is Lung Cancer Screening, Diagnosis, and Management”

American College of Chest Physicians World Congress Meeting, Spain, March 20-25, 2014 Chair: Multidisciplinary Care in Lung Cancer

Speaker: “The Impact of Multidisciplinary Thoracic Oncology Programs on Lung Cancer Outcomes”

Revised: 2/7/2020 - 20 -

2013 The 19th Annual Fall Oncology Symposium: Diagnosis and Management of Lung Cancer: New Guidelines and New Approaches" Saginaw, MI November 16, 2013 Speaker: “Lung Cancer Staging: The Guidelines” American College of Chest Physicians Annual Meeting October 27-31, 2013

Speaker: ACCP Lung Cancer Guidelines: “Diagnosis, Staging and Symptom Management”.

American Thoracic Society Annual Meeting May 17-2, 2013 Co-Chair: Post Graduate Course: Lung Cancer 2013

Speaker: “Lung Cancer in Women: Differences in Epidemiology and Outcomes: The Role of Hormone Receptors”

American Thoracic Society Fellows Track Symposium 2013 Speaker: “Lung Cancer: State of the Art” 2012 XXXVI Congresso Brasileiro De Pneumologia E Tisiologia, Belo Horizonte, Brazil, November 26-29, 2012

Speaker: “Pulmonary Evaluation of the Lung Resection Candidate” “Lung Cancer in Women”

“Screening for Lung Cancer” American Thoracic Society Annual Meeting May 18-22, 2012 Co-Chair: Post Graduate Course: Lung Cancer in 2012: State of the Art

Speaker: “Lung Cancer in Women” Clinical Year in Review 2012

Speaker: “Lung Cancer” 2011 American Thoracic Society Annual Meeting May 13-17, 2011 Co-Chair: Post Graduate Course: Lung Cancer in 2011: State of the Art

Speaker: “Lung Cancer in Women: Differences in Epidemiology, Biology and Outcomes”

Asociacion Argentina de Medicina Respiratoria, VI Conferenceia Buenos Aires, II Conferencia Latinoamericana, Enfoque Multidisciplinario del Cáncer de Pulmón, Mayo 5-7, 2011

“El rol del Neumonólogo en la Estadificación del Cáncer de Pulmón” “Métodos diagnósticos en Cáncer de Pulmón” “Evaluación preoperatoria”

“Cáncer de Pulmón en la Mujer”

2010 American College of Chest Physicians Annual Meeting Oct 30-November 4, 2010 “Bronchioloalveolar Carcinoma”: When and How to treat “Lung Cancer: Beyond the 5-year survival: Co-morbidities and 2nd Lung Cancers

Revised: 2/7/2020 - 21 -

2009 American College of Chest Physicians Annual Meeting October 31-November 3, 2009 Co-Chair and speaker Postgraduate Course: Lung Cancer “Diagnostic Tools in Lung Cancer” Speaker Postgraduate Course: “Literature Review: Lung Cancer” Lung Cancer Symposium 2009: “The five articles that will change your practice,” Women and Lung Diseases: “Lung cancer in women: Is it a different disease American Thoracic Society Annual meeting, May 18-21, 2009 “Women and Lung Cancer” Sixth Annual Lung Cancer Winter Conference, Miami Florida March 6-8, 2009 “Pulmonary Therapeutic Advancements in Patients with Lung Cancer” Society of Thoracic Surgery, February 27 to March 1, 2009 “Role of Tumor Markers in the Diagnosis of Malignant Pleural Effusions” 2008 XXXIV Congresso Brasileiro De Pneumologia E Tisiologia, Brasilia, Brazil, November 21-25, 2008

“Pulmonary Evaluation of the Lung Resection Candidate” “Targeted Therapy in Non-Small Cell Lung Cancer”

American College of Chest Physicians Annual Meeting, October 27-31, 2008 Postgraduate Course: Literature Review: Lung Cancer” American Thoracic Society, Pulmonary and Allergy Fellows Symposium, May 13-15, 2008,

“Lung Cancer: A Review” Fifth Annual Lung Cancer Winter Conference, Miami FL, March 9-11, 2008

“Pre-operative Approach to the Lung Resection Candidate” “Pulmonary Complications Following Treatment for Lung Cancer”

2007 American College of Chest Physicians Annual Meeting, October 2007

“Lung Cancer Literature Review” “Lung Cancer “Top Five” in 2007”

“Developing a Multidisciplinary Thoracic Oncology Program in an Academic Center”

American Thoracic Society Annual Meeting, May 21-24, 2007 “Targeting Therapies in Patients with NSCLC” “Adjuvant and Neoadjuvant Therapy in Early Stage NSCLC”

Fourth Annual Lung Cancer Winter Conference, Miami FL, March 16-18, 2007 “Pulmonary Complications After Treatment for Lung Cancer”

Revised: 2/7/2020 - 22 -

2006 American College of Chest Physicians Annual Meeting, October 20-25, 2006 Postgraduate Course: “Literature Review: Lung Cancer” Speaker Panel Discussion: Update on Lung Cancer 2006 “Screening and Early Detection” European Respiratory Society Annual Meeting, Munich, Germany, September 2-6, 2006

“Pulmonary Complications of Treatment for Lung Cancer” Society of Thoracic Surgery and American College of Chest Physicians, Multidisciplinary Care of Thoracic Patients: Clinical Updates and Hands-on Workshops, Chicago August 25-27, 2006

“The Role of Adjuvant Therapy in Early Stage NSCLC” “Multidisciplinary Tumor Board Clinical Presentations”

14th World Congress for Bronchology, Buenos Aires, Argentina, June 25-28, 2006 “Indications for Adjuvant Therapy in NSCLC”

“Adjuvant and Neoadjuvant Therapy in NSCLC Surgical Patients American Thoracic Society Annual Meeting, May 21-24, 2006 Chair and Speaker, Panel Discussion: Multidisciplinary Approach to Lung Cancer “Targeted Therapies in NSCLC” American Thoracic Society, Pulmonary and Allergy Fellows Symposium, May 15-18, 2006

“Lung Cancer: A Review” 2nd Annual Pacific North West Thoracic Oncology Conference, Seattle April 28-30, 2006 “Diagnostic Approach in the Patient with Suspected Lung Cancer” “Pre-operative Evaluation of the Patient with Lung Cancer” Third Annual Lung Cancer Winter Conference, Miami FL, March 9-11, 2006

“Complications of Radiation Therapy” 2005 American College of Chest Physicians Annual Meeting, October 25-Nov 2, 2005 Postgraduate Course: “Literature Review: Lung Cancer” Chair and Speaker, Panel Discussion: “Lung Cancer, There’s More Since 2004”

“Targeted Therapies in the Treatment of Lung Cancer” American Thoracic Society Annual Meeting, May 20-25, 2005 Clinical Year in Review: “Lung Cancer”

Panel Discussion: “Complications of Therapy for Lung Cancer: Complications of Radiation Therapy”

Second Annual Lung Cancer Winter Conference, Florida, March 18-20, 2005

“Complications of Combined Modality Therapy for Locally Advanced NSCLC”

2004

Revised: 2/7/2020 - 23 -

American College of Chest Physicians Annual Meeting, October 23-27, 2004 Postgraduate Course: “Literature Review: Lung Cancer”

Panel Discussion: “Health Care Discrepancies in Minorities: “Lung Cancer in Minorities” Panel Discussion: “Lung Cancer, What’s Key Since 2003”

International Meeting in Respiratory Endoscopy, Barcelona, Spain June 20-23, 2004 Symposium: The Societal Implications of Mass screening for Lung Cancer “How to Manage the Solitary Nodule Detected on CT Scan”

University of Cincinnati and the Barrett Cancer Center Fourth Annual Lung Cancer Symposium June 19, 2004 “The Role of the Pulmonary Physician in the Management of Lung Cancer” Canadian Thoracic Society Meeting, June 11, 2004 Staging of Lung Cancer: The Guidelines American Thoracic Society Annual Meeting, May 21-26, 2004 Panel Discussion: “Evidence-Based Approach to Thoracic Malignancies” “Is There an Optimal Algorithm for Lung Cancer Staging?” 2003 American College of Chest Physicians Annual Meeting, October 25-30, 2003 Postgraduate Course: “Literature Review: Lung Cancer” Postgraduate Course: “Diagnosis of Lung Cancer: The Guidelines” Panel Discussion: “Initial Evaluation and Diagnosis of the Lung Cancer Patient” The 6th Annual Congress of the Turkish Thoracic Society in April 20-25, 2003 Postgraduate Course- Lung Cancer: “Diagnosis and Staging in Lung Cancer”

Meet the Professor Session: “Epidemiology of Lung Cancer: Is There Any Change?”

Meet the Professor: “Diagnosis and Staging of Lung Cancer: The Guidelines” 2002 American College of Chest Physicians Annual Meeting, November 4 – 7, 2002 Postgraduate Course: “Literature Review: Lung Cancer” Postgraduate Course: “Lung Cancer Guidelines: An Update” Chair and Speaker Satellite Symposium: “Targeted Therapy in the Multimodality Treatment of Lung Cancer” American College of Chest Physicians Key Trends in Chest Medicine Postgraduate Course San Juan Puerto Rico March 8-9 2002 “Diagnosis and Staging of Lung Cancer” 2001 American College of Chest Physicians Annual Meeting November 4-8, 2001 Postgraduate Course “Evidence Based Guidelines for Diagnosis of Lung Cancer”

Revised: 2/7/2020 - 24 -

Chair and Speaker Satellite Symposium: “Early Detection and Combined Modality Treatment of Lung Cancer”

Institut Catala de la Salut Ciutat Sanitaria i Universitaria de Bellvitge, Barcelona, Spain The VII International Congress on Respiratory Endoscopy, April 18-20, 2001 Honor Lecture: “Multimodality Treatment of Lung Cancer” 1997-2000 American College of Chest Physicians Annual Meeting, October 21, 2000

“The Emerging Role of the Pulmonologist in Multidisciplinary Lung Cancer Programs” “Advances in the Treatment of Stage IV Non-Small Cell Lung Cancer” “Multimodality Approach to the Diagnosis and Staging of Non-Small Cell Lung Cancer”

American Thoracic Society Annual Meeting, May 9-12, 2000 Lecture: “Stage IIIa Nemesis: Will the Addition of Surgery to Chemotherapy and Radiation Therapy be of Benefit?”

Chairperson Lung Cancer Poster Sessions American College of Chest Physicians Annual Meeting, November 3, 1999

Moderator: Pleural Disease Speaker: “The Role of the Pulmonologist in a Multimodality Lung Cancer Program”

American Thoracic Society Annual Meeting, May 1998 The Year in Review: “Lung Cancer” American Thoracic Society Annual Meeting, May 1999

Moderator: Treatment of Lung Cancer Poster Symposium American College of Chest Physicians Annual Meeting, November 7-11, 1998 Chair, Lung cancer section Moderator: Multimodality Approach to NSCLC Speaker: “Lung Cancer: An Overview”

American College of Chest Physicians Annual Meeting, October 26-30, 1997 Chair: “Novel Detection Methods for Lung Cancer: Panel Discussion” Meet the Professor: “Treatment of Advanced Non-Small Cell Lung Cancer” Moderator: “Clinical presentations on Pleural Disease” Grand Rounds At UNC – Department of Medicine Grand Rounds January 25, 2019

“Empyema Thoracis: Diagnostic Challenges and New Insights into an Old Disease’

Revised: 2/7/2020 - 25 -

Department of Medicine Grand Rounds October 1, 2015

“Lung Cancer Screening: Beyond the NLST” Department of Medicine Grand Rounds January 17, 2013 “Lung Cancer Screening: An Update” Department of Medicine Morbidity and Mortality Conference June 9, 2011 “Management of Lung Abscess” Department of Medicine Grand Rounds June 4, 2005

“Smoking Cessation: Clinical Benefits”

Department of Medicine Grand Rounds, January 9, 1997 “Pleural Disease: An Update” Outside UNC -

St. Vincent’s Hospital NY, NY Medical Grand Rounds October 27, 2006 “Targeting Therapy in Patients with Non-Small Cell Lung Cancer” Medical Grand Rounds at the Lahey Clinic, Boston MA, April 1st, 2005 “Epidermal Growth Factor Receptor Antagonists in Lung Cancer Therapy”

Saint Anthony Hospital, Oklahoma City Medical Grand Rounds, July 19, 2001 “Non-Small Cell Lung Cancer: An Overview” St. Vincent’s Hospital, NY, NY Department of Medicine Grand Rounds, January 28, 2000

“Lung Cancer: State of the Art in Treatment and Screening” Carolinas Medical Center, Charlotte NC Department of Medicine Grand Rounds, January 22, 1997 “Multimodality Therapy for Non-Small Cell Lung Cancer” Wilford Hall Medical Center, Lackland AFB, TX Department of Medicine Grand Rounds, December 5, 1997 “Multimodality Approach to Non-Small Cell Lung Cancer” Nash General Hospital Department of Medicine Grand Rounds, September 19, 1995 “New Treatment Approach to Advanced Lung Cancer” Continuing Education Lecture: At UNC Annual Internal Medicine Conference, March 7, 2018 “Screening in Lung Cancer: Beyond the NLST”

Revised: 2/7/2020 - 26 -

Annual Internal Medicine Conference, March 17, 2011 “Screening in Lung Cancer”

Annual Internal Medicine Conference, April 10, 2008 Symposium: “Multimodality Approach to Lung Cancer” Lecture: “Screening for Lung Cancer”

HIV Symposium, University of North Carolina at Chapel Hill May 7th, 2007 “Smoking Cessation: Update” Annual Internal Medicine Conference, March 8, 2001

“Screening for Lung Cancer: An Update”

University of North Carolina at Chapel Hill School of Nursing Acute and Chronic Respiratory Disorders Workshop, October 11, 2000 “The Latest in Screening and Treatment of Lung Cancer” Department of Medicine Clinical Pathologic Conference, March 28, 2000 “A 49-Year-Old Man with Cough and Bilateral Pulmonary Nodules”

Annual Internal Medicine Conference, March 1999 Symposium: “Multimodality Approach to Lung Cancer” Department of Medicine Clinical Pathologic Conference, October 13, 1998 “A 52-year-old man with bilateral pulmonary infiltrates and hypoxemic respiratory failure”

UNC-LCCC Multidisciplinary Thoracic Oncology Conference, October 3, 1977 “The Light-Induced Fluorescent Bronchoscope: Clinical Trial” Cardiothoracic Surgery Symposium: What’s New in Thoracic Surgery, May 9, 1997 “Preoperative Physiologic Assessment of the Lung Resection Candidate”

Department of Medicine Morbidity and Mortality Conference, January 7, 1997 “Thoracentesis: Technique/Complications/Contraindications” Multidisciplinary Thoracic Oncology Program Conference, October 15, 1996 “Diagnosis of Lung Cancer” (30 min lecture) Annual Internal Medicine Conference, March 22, 1996 Symposium: “Multimodality Approach to Lung Cancer” Lecture: “Diagnosis and Staging of Lung Cancer Department of Medicine Clinical Pathologic Conference, September 12, 1995 “Cavitary Lesion in an HIV Positive Patient”

Annual Internal Medicine Course, March 1995 “Lung Cancer in the 1990’s”

Revised: 2/7/2020 - 27 -

Outside UNC Duke University, Interstitial Lund Disease Symposium January 16, 2010

“Chemotherapy Induced Interstitial Lung Disease” American Lung Association, NC Chapter, November 8th, 2006 “Update on Treatment of Lung Cancer” The New York State Thoracic Society Annual Meeting, February 3, 2006 “Targeted Therapy in Non-Small Cell Lung Cancer” The Cleveland Clinic Foundation, Cleveland OH, September 21st, 2005 “Therapy in Non-Small Cell Lung Cancer: An Update” The Massachusetts Thoracic Society Annual Meeting, March 30th, 2005 “Lung Cancer: Update of Therapy” The Virginia Thoracic Society Annual Meeting, October 2004 “Non-Small Cell Lung Cancer: Medical Management” “Small Cell Lung Cancer: An Update” Henry Ford Hospital, Detroit MI

Visiting Professor, Division of Pulmonary and Critical Care Medicine, February 6, 2004 “The Role of Pet Scan in NSCLC” Wake Forest University Cancer Symposium, Greensboro, NC, November 7-8, 2003 “LIFE: Light Imaging Fluorescence Endoscope”

The First Annual Tri-State Lung Cancer Symposium June 2, 2001 The Barrett Cancer Center, University of Cincinnati, College of Medicine “Workup and Staging of Lung Cancer: An Update” Thoracic Oncology Center of Lexington Kentucky, October 14-15, 2000 Second Annual Symposium “Early Detection and Prevention of Lung Cancer”

The Cancer Institute of New Jersey, Morristown, NJ First Annual Lung Cancer Symposium, October 15, 1999 “Approach to the Solitary Pulmonary Nodule” Inova Fairfax Hospital, Fairfax VA Fifth Annual Conference in Advances in Pulmonary Medicine, October 8, 1999

“Multimodality Approach to Non-small Cell Lung Cancer”

Creighton University School of Medicine, Omaha, NE Symposium: Advances in the Treatment of Lung Cancer” April 17, 1999 “Multidisciplinary Approach to the Diagnosis and Staging of Lung Cancer”

Revised: 2/7/2020 - 28 -

The Laennec Medical Society Annual Lecture, Philadelphia, PA, February 9, 1999

“Non-Small Cell Lung Cancer: The Pulmonary Physician’s Perspective and Role”

First Annual Duke University and University of North Carolina at Chapel Hill Cancer Symposium: “Critical Issues in Thoracic Oncology”, November 13-14, 1998 “State of the Art in Early Detection/Bronchoscopy”

Wake Medical Center and Dorothea Dix Hospital (AHEC), October 21, 1998 “Multimodality Approach to NSCLC”

Oklahoma Medical Center The Second Annual Cy Young Symposium, October 8, 1998 “Lung Cancer: An Overview” Arlington Hospital, Arlington VA Department of Medicine Tumor Board, June 11, 1998 “New Staging Techniques and New Diagnostic Procedures for NSCLC” Cooper Medical Center, Voorhees NJ Symposium: A Comprehensive, Multidisciplinary Approach to Lung Cancer June 3, 1998 “Diagnosis and Staging” St. Barnabas Medical Center, Livingston NJ Clinical Symposium: Lung Cancer: New Frontiers in Diagnosis and Management, October 22, 1997 “An Approach to the Solitary Pulmonary Nodule”

Pender Memorial Hospital (AHEC), February 4, 1997 “Multimodality Therapy for Lung Cancer” Postgraduate and Learning Courses: American Thoracic Society:

1. Co-Chair: Lung Cancer: State of the Art 2020 2. Co-Chair: Lung Cancer: State of the Art 2019 3. Co-Chair: Lung Cancer: State of the Art 2018 4. Co-Chair: Lung Cancer: State of the Art 2017 5. Co-Chair: Lung Cancer: State of the Art 2016 6. Co-Chair: Lung Cancer: State of the Art 2015 7. Co-Chair: Lung Cancer: State of the Art 2014 8. Co-Chair: Lung Cancer: State of the Art 2013 9. Co-Chair: Lung Cancer: State of the Art 2012 10. Co-Chair: Lung Cancer: State of the Art 2011

American College of Chest Physicians

Revised: 2/7/2020 - 29 -

1. Co-Chair CHEST 2019 Live Learning Course: Decision Counseling Shared Decision Making and Navigation in Lung Cancer Screening

2. Co-Chair Post Graduate course: Lung Cancer 2019 3. Co-Chair Post Graduate course: Lung Cancer 2018 4. Co-Chair Post Graduate course: Lung Cancer 2017 5. Co-Chair Post Graduate course: Lung Cancer 2016

Clinical Service Multidisciplinary Thoracic Oncology Clinic and Lung Cancer Screening Clinic, 1 full day/week Attending on the in-patient pulmonary service, on average 8 weeks each year Attending on the in-patient pulmonary consult service, on average 6 weeks each year Precepting Pulmonary Fellows Clinic, average 10 clinic days each year Procedures: Bronchoscopy, EBUS Grants/Awards ACTIVE: 1. UNC Lineberger Comprehensive Cancer Center Award 07/01/18-06/30/20 PIs: Louise M. Henderson, PhD and M. Patricia Rivera, MD $175,000 A Multidisciplinary Collaboration to Assess Use of Guideline Recommended Molecular Biomarker Testing in Rural Versus Urban Lung Cancer Patients The objective of this pilot application is to explore rural/urban disparities associated with biomarker testing. We will accomplish this by linking lung cancer pathology reports from the UNC Lineberger Comprehensive Cancer Center Rapid Case Ascertainment Program with access and contextual factors from U.S. Census data to evaluate the impact of recent molecular advances in lung cancer treatment on health disparities. 2.NIH/NCI R01CA2120101A1 09/15/17-08/31/22 PI: Louise M. Henderson, PhD $500,000 Co-Investigator: M. Patricia Rivera, MD (25% effort) Evaluating Lung Cancer Screening Patterns and Outcomes in a North Carolina Registry The goal of this proposal is to examine the delivery, quality and outcomes of lung cancer screening in North Carolina by utilizing prospective population-based lung cancer screening data that captures patient, radiologist, and pathology information to inform clinical practice. 3.Carolinas Collaborative Grant NC Translational and Clinical Sciences Institute. 03/01/19-2/29/20 PIs: Tina Taylor, MD, Louise Henderson , PhD, Caroline Chiles, MD $75,000 Co-Investigator (UNC site): M. Patricia Rivera, MD Detection of Coronary Artery Calcification in the Lung Cancer Screening Population: Clinical Implications for Cardiovascular Risk Stratification and Statin Pharmacotherapy Through a multi-site collaboration, we will assess the feasibility of collecting and harmonizing lung cancer screening and finding data across sites.

Revised: 2/7/2020 - 30 -

PENDING: 1.NIH/NCI R01CA251686-01 07/01/20-06/30/24 PIs: Louise M, Henderson, PhD and M. Patricia Rivera, MD $2,195,547 Comorbidity and Functional Status in a Population-Based Cohort of Patients Screened for Lung Cancer The objective of this application is to evaluate the extent to which patient comorbidities and functional status impact LCS outcomes in a population-based setting. Our proposal makes innovative use of an existing population-based registry of patients screened for lung cancer in North Carolina. We will link this screening data with administrative claims data to (1) augment the capture of comorbid conditions; (2) measure proxies for functional status and estimate life expectancy; and (3) determine the downstream consequences of screening. Received a score of 7% on February 20, 2020. COMPLETED 1.NIH/NCI R21CA175983 01/01/14-12/31/16 PI: Louise M. Henderson, PhD $275,000 Co-Investigator: M. Patricia Rivera, MD (5% effort) Developing a lung cancer screening registry in a state with a high smoking rate The goals of this study are to develop, and pilot test a lung cancer screening registry prototype and obtain information on the extent of lung cancer screening in the state of NC. This pilot will serve as a proof of concept, demonstrating the feasibility of establishing a larger population-based registry, while collecting preliminary data. 2.UNC IHQI Grant: Improving the Implementation of Lung Cancer Screening Guidelines. July 1, 2015 to June 30, 2016 Role co-Investigator (5% support) 3.UNC Lineberger Comprehensive Cancer Center Clinical Innovation Award 2009- 2013 Amount $35,000 Study Title: Gene expression profiling of bronchial and nasal epithelial cells: A novel approach to screening high risk patients for lung cancer Role: Principal Investigator 4.LCCC 0808. Radiation-induced cardiopulmonary injury in humans. Lawrence B. Marks PI Role: Co-Investigator (5% effort) Completed: NIH (Marks) 7/1/08-11/30/12 Role: Co-Investigator (5% support) 5.UNC Lineberger Comprehensive Cancer Center Clinical/Translational Research Award 2000-2003 Amount $35,000 Study Title: Fluorescence Bronchoscopy and Molecular Characterization of Abnormal Bronchial Lesions: Novel Approaches for Early Detention of Lung Cancer in High Risk Patients

Revised: 2/7/2020 - 31 -

Role: Principal Investigator American Thoracic Society Funded Proposals

1. Co-Chairs: Melissa Aldrich, PhD, Louise Henderson PhD and M. Patricia Rivera, MD. Budget: $11,885 Title: Addressing Disparities in Lung Cancer Screening Eligibility and Health Care Access: A Policy Statement. Workshop held May 18, 2019 Manuscript in progress

2. Co-Chairs: Katherine Sears, MD and M. Patricia Rivera, MD. Budget: 16,230 Title: Knowledge Gaps in Immunotherapy Induce Lung Injury: A Research Agenda. Workshop held Friday May 18, 2018. Completed. Manuscript published AJRCCM 9/2019.

3. Co-Chairs: M. Patricia Rivera, MD, Nichole Tanner, MD, Renda Weiner, MD. Budget: $16,245. Title: Evaluation of Coexisting Chronic Illness in Selecting Patients for Lung Cancer Screening: A Research Agenda Workshop held May 20, 2017. Completed. Manuscript published AJRCCM 7/2018.

Professional Service: To Discipline: State –

Governor from North Carolina for the American College of Chest Physicians 2001 – 2003

Governor from North Carolina for the American College of Chest Physicians 1999 - 2001 National – Member, Executive Scientific Program Committee, CHEST 2020

Member, ABIM Pulmonary Exam Committee, September 2020- Chair, National Lung Cancer RoundTable: Biomarker Task Force 2019- Member, Program Review Subcommittee, American Thoracic Society 2019- Member Scientific Program Committee, CHEST 2019 Member Finance Committee, American Thoracic Society 2018-2019

Member, Planning and Evaluation Committee, American Thoracic Society 2018- Member, Committee to Select Executive Director of ATS, 2017-2018 Member, Membership Committee, International Association for the Study of Lung Cancer 2017- Member, National Lung Cancer RoundTable: Triage for Appropriate Staging and Treatment Task Group 2017- Vice Chair, National Lung Cancer RoundTable: Lung Cancer in Women Task Force 2017- Member, Committee to Select Executive Director of ATS, 2017 American Thoracic Society Board of Directors 2016-2019 Chair, Thoracic Oncology Assembly, American Thoracic Society 2017-2019

Revised: 2/7/2020 - 32 -

Chair-Elect, Thoracic Oncology Assembly, American Thoracic Society 2016-2017 Chair, Thoracic Oncology Network, American College of Chest Physicians 2018- Vice Chair, Thoracic Oncology Network, American College of Chest Physicians 2016-2018 Member, Chest Physician Editorial Board 2016- Member, Thoracic Oncology Network, American college of Chest Physicians 2015- Member of the Thoracic Oncology Assembly Panning Committee of the American Thoracic Society 2013-present Chair, Nominations Committee, Thoracic Oncology Assembly 2013-2015 Member of the Clinical Problems Assembly Planning Committee of the American Thoracic Society 2011-2015 Member of the Medical and Scientific Advisory Board of the Lung Cancer Alliance 2005-Present Member, Nominations Committee, American College of Chest Physicians 2005-2008 Member, Government Relations Committee, American College of Chest Physicians 2005-2008 Trustee, the CHEST Foundation 2003-2007 Co-Chair, Steering Committee, American College of Chest Physicians Lung Cancer Diagnosis/Treatment Initiative 2003-2007

Chair, Thoracic Oncology Network, American College of Chest Physicians 2002-2004 Member, Clinical Problems Program Committee, American Thoracic Society 2002-2004

Liaison: Chest 2003 Scientific Program Committee Member, Membership Committee, American College of Chest Physicians 2001-2003 Vice-Chair, Thoracic Oncology Network, American College of Chest Physicians 2000- 2002

Chair, Cancer Steering Committee, American College of Chest Physicians 1997- 1998 Co-Chair, Cancer Steering Committee, American College of Chest Physicians 1996-1997 Member of the Affiliates Committee, American College of Chest Physicians 1993-1997 International: Member, Membership Committee, International Association for the Study of Lung Cancer (IASLC) 2018- Member, Planning Committee, International Symposium on Respiratory Diseases & ATS 2018-

Editorial appointments: Member, Thoracic Oncology Editorial Board of Chest 2019-

Member of the Editorial Board of CHEST Physician 2017- Member of the Editorial Board of the Journal CHEST 2005-2010 Member of the Editorial Board “Lung Cancer Frontiers” 2000-2006

Reviewer for Journal: CHEST Thorax European Journal of Respiratory Diseases Annals of American Thoracic Society

American Journal of Respiratory and Critical Care Medicine Lung Cancer

Revised: 2/7/2020 - 33 -

Within UNC – School of Medicine: Committees: Member Professors APT Committee 2019-

Member, Post-Tenure Review Committee 2019-present Member, Five-year review of the Chairman of OB-GYN 2017

Member Associate Professors APT Committee 2017-2019 Co-Chair Department of Medicine Diversity and Inclusion Task Force 2015-present Member search committee for new Chief of Nephrology 2016 Mentor for the Latino Medical Student Association 2015-present Innovation Grant Program “After the Match: Cultivating a Community of Support, Retention and Mentoring to Enhance Diversity” 2016-present Member, at-large, UNC Faculty Practice Board 2016-2018 Member of the School of Medicine Task Force on Academic Vulnerabilities 2014-present

Member, Medical Staff Executive Committee 2014-2016 Member, Medical Student Promotions Committee 2008-2018 Medical School Curriculum Planning Committee 2005-2007

Member, Search Committee for new Chairperson of the Department of Radiology 2005 -2006

Other Administrative Activities (Division, Clinic, Section or team) Director of the Lung Cancer Screening Program 2015- Medical Director of the UNC-REX Pulmonary practice May 2011-2014

Director of Bronchoscopy and Pulmonary Function Laboratory, University of North Carolina at Chapel Hill 2006- present Service Chief Leader, Pulmonary in-patient service, 2006-present Director of Clinical Operations, Pulmonary and Critical Care Division, Department of Medicine, University of North Carolina at Chapel Hill 2006-2011 Director, UNC Multidisciplinary Thoracic Oncology Program 2004-2010 Co-Director, UNC Pulmonary/Critical Care Fellowship Program 1996-2005 Co-Director, UNC Multidisciplinary Thoracic Oncology Program 1995-2004